Drug details

Revonto (dantroene sodium injection)

type of Skeletal Muscle Relaxants

Revonto (dantrolene sodium for injection) is a skeletal muscle relaxant indicated, along with appropriate supportive measures, for the management of fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. Revonto is also indicated preoperatively and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• upper stomach pain,
• loss of appetite,
• itching,
• dark urine,
• severe drowsiness,
• tiredness,
• clay-colored stools,
• yellowing of the skin or eyes (jaundice),
• painful or difficult urination,
• lightheadedness
• weak or shallow breathing,
• severe muscle weakness,
• problems with vision or speech,
• seizure, and
• severe or ongoing vomiting or diarrhea,

The following drugs are related to Revonto, either as a replacement or used together:

• Dantrium Capsules (dantrolene sodium capsules)
• Dantrium IV (dantrolene sodium for injection)
• Ryanodex (dantrolene sodium injectable suspension)
• Suprane (desflurane)
• Quelicin (succinylcholine chloride injection)